Potentially deadly zoonotic virus found in US, sparking concerns of spread to humans
A fatal virus has reportedly been discovered in shrews in Alabama, sparking concerns about potential contagion to humans.
The Camp Hill virus — thought to be the first "henipavirus" in North America — was discovered by researchers at The University of Queensland.
A henipavirus is a genus of viruses that is zoonotic, which means it can be spread from animals to humans.
"Henipaviruses have caused serious disease and death in people and animals in other regions," Dr. Rhys Parry from the School of Chemistry and Molecular Biosciences said in a press release on The University of Queensland's website.
"The closest known henipavirus to Camp Hill virus that has caused disease in humans is Langya virus, which crossed from shrews to humans in China," the researcher said. "This indicates that shrew-to-human transmission can occur."
Another dangerous henipavirus is the Hendra virus, which was first detected in Brisbane, Australia and has a fatality rate of 70%, according to Parry.
Another cited example is the Nipah virus, which has shown between 40% and 75% fatality rates in Southeast Asia (Bangladesh and India).
"The discovery of a henipavirus in North America is highly significant, as it suggests these viruses may be more globally distributed than previously thought," Parry added.
The Camp Hill virus was detected in northern short-tailed shrews, a small mammal that is commonly found in the U.S. and Canada, according to the press release.
More research is needed to determine whether the virus poses any threat to humans, Parry said.
Queensland researchers plan to work on developing vaccines for this family of viruses, according to Dr. Ariel Isaacs, another researcher at the university.
"The next step for this work is to characterize key surface proteins on the virus that are involved in cell entry to broaden our understanding of the virus family and identify better ways to protect against it," Isaacs said in the release.
Those at highest risk of contracting a henipavirus are travelers who are exposed to infected animals (primarily bats and pigs) or who eat foods contaminated by those animals' body fluids, according to the U.S. Centers for Disease Control and Prevention (CDC).
Health care workers treating infected patients are also at a higher risk.
To prevent infection, the CDC recommends avoiding "unprotected contact" with potentially infected animals and their body fluids, following safe food precautions, and using personal protective equipment and barriers in medical settings.
For more Health articles, visit www.foxnews.com/health
There is no specific antiviral treatment for henipavirus infections, according to the same source.
"Therapy consists of supportive care and management of complications," the CDC's website states.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Hundreds of CDC employees reinstated after being laid off
The Brief Over 460 CDC employees have been reinstated after April layoffs, mainly from public health divisions. Thousands of jobs remain unfilled, with no word on further reinstatements. RFK Jr. appointed eight new vaccine advisers, including controversial figure Dr. Robert Malone. ATLANTA - More than 460 employees at the Centers for Disease Control and Prevention (CDC) have been reinstated after being laid off earlier this year, the U.S. Department of Health and Human Services (HHS) confirmed Wednesday, according to the Associated Press. What we know The employees are among the approximately 2,400 CDC staffers let go in April, a move that sparked widespread backlash and legal challenges. According to HHS, the reinstated workers include 200 employees from the Center for HIV, Hepatitis, STD and Tuberculosis Prevention and another 150 from the Environmental Health division, which includes a lab focused on lead poisoning prevention. PREVIOUS STORIES Reactions to mass layoffs underway at Atlanta-based CDC 2,400 CDC jobs to be cut in HHS overhaul announced by Secretary Kennedy CDC to lose nearly 1,300 probationary employees under Trump's job cuts Former employees and public health advocates have criticized the layoffs for leaving vital public health positions vacant. Reese Williams, a former CDC worker, said the terminations affected key personnel. "They fired a lot of our scientists, a lot of our public health communicators, a lot of anybody to do with DEI, birth defects, anything to do with smoke and health, domestic abuse and domestic violence," Williams said. Williams says the 2,400 roles that were eliminated this year played a critical role in public health. "They took a part a lot of the funding for our global partners. Funding that goes for Ebola or for these diseases that don't necessarily effect us, but could effect us, they took away a lot of that," she said. This is the second wave of reinstatements. In February, about 180 employees who were laid off were later asked to return. Despite the new round of rehirings, thousands of jobs remain unfilled, and officials have not indicated if additional reinstatements are forthcoming. Employees say many vital positions are still left empty. "Eventually, we will all feel this. Even the ones who think they won't feel it. We're going to feel it," Reese said. Meanwhile, HHS Secretary Robert F. Kennedy Jr. has appointed eight new members to the federal vaccine advisory committee. The move follows his abrupt dismissal of the previous panel earlier this week. Among the new appointees is Dr. Robert Malone, a controversial figure known for spreading misinformation about COVID-19 and vaccines. RELATED STORIES RFK Jr.'s newest CDC vaccine panel includes critics of COVID shots, lockdowns Protest against CDC vaccine committee firings held at Atlanta headquarters RFK Jr. ousts entire CDC vaccine panel The committee advises the CDC director on how approved vaccines should be used nationwide.
Yahoo
44 minutes ago
- Yahoo
RFK Jr.'s latest big move could leave you paying more for vaccines
Health Secretary Robert F. Kennedy Jr. sent shockwaves through the scientific community this week when he fired all 17 members of the federal government's key vaccine advisory board, raising concerns that he might try to replace them with immunization skeptics. Those fears were confirmed for many on Wednesday when Kennedy unveiled eight new members who included some of the most prominent critics of the COVID-19 vaccines. The swap could have wide-reaching public health consequences. But one of the most straightforward impacts may be on consumers' wallets. That's because recommendations by the board — known as the Advisory Committee for Immunization Practices, or ACIP — determine which vaccines most insurance plans are required to cover at zero cost, such as inoculation against measles or your annual flu shot. If the new members decide to reverse the panel's old guidance, patients could find themselves paying out of pocket for vaccines that were once available for free. 'For the average person who has never heard of ACIP before, this could affect their access to vaccines,' said Jennifer Kates, a senior vice president at the healthcare think tank KFF. Created in 1964, ACIP is the official outside panel of medical experts responsible for advising the Centers for Disease Control and Prevention (CDC) on what to include on its lists of routine shots for both children and adults. While its recommendations aren't binding, federal officials have typically adopted them. As a result, the board's decisions carry enormous weight, affecting patients and parents, as well as the vaccines schools require for students. Over the years, the panel has played a growing role in determining insurance coverage as well. By law, shots recommended by ACIP must be covered by the free Vaccines for Children program, the Children's Health Insurance Program, Medicaid, and Medicare Part D. The Affordable Care Act also requires private insurers to pay for vaccines with no cost sharing if they have the panel's seal of approval. (Past administrations have said the rule only applies if the CDC also adopts the board's recommendation.) In a Wall Street Journal op-ed this week, Kennedy said his decision to replace the board was meant to fight a 'crisis of public trust' in vaccines by ridding the committee of what he described as 'persistent conflicts of interest.' (Kennedy's critics have argued that his allegations against ACIP's former members are unfounded.) His new picks for the panel include several figures who rose to national fame by casting doubt on the safety of COVID-19 vaccines. Among them is Dr. Robert Malone, an accomplished scientist who did pioneering work on mRNA technology but later attacked its use in shots during the pandemic and who was at one point banned from Twitter for spreading COVID misinformation. He'll be joined by Retsef Levi, an MIT business school professor who gained attention in 2023 for claiming there was 'indisputable evidence' that 'MRNA vaccines cause serious harm including death,' and Dr. Martin Kulldorff, who advocated letting COVID spread among younger Americans to achieve 'herd immunity' and was later let go from Harvard Medical after refusing to be vaccinated. In his announcement, Kennedy said that each new member of ACIP was 'committed to demanding definitive safety and efficacy data before making any new vaccine recommendations' — suggesting they'll be less likely to add new shots to the government's immunization schedules. But he added that the board will also 'review safety and efficacy data for the current schedule as well,' raising the possibility that it will scrap some of its old recommendations. Even before this week's shake-up, the government had already begun changing its recommendations on COVID shots. In May, the CDC dropped its recommendation that healthy pregnant women receive the vaccine and revised its guidance for young children, saying they should only receive it after consultation with a doctor. Private insurers could still choose to cover vaccines even if the federal government stops recommending them. Whether they will is less certain. 'That's territory we haven't really had to traverse before,' said KFF's Kates. Sarah Moselle, a vaccine market expert at the health industry consulting firm Avalere, said there may be some 'fragmentation' in how carriers approach the issue. Some may drop coverage entirely or begin requiring co-pays. But many 'do anticipate that they would continue to cover some vaccines,' even if they aren't required to, since it would 'add value' for their customers, she said. In theory, insurers could also have an incentive to maintain vaccine coverage since it could keep their patients healthier and reduce the costs of their care, though it's unclear exactly how those savings would stack up against the added expense of paying for shots. For many vaccines, the out-of-pocket cost might be relatively cheap for patients. But others could turn out to be steep. Take Gardasil, the HPV vaccine that has been the focus of growing safety concerns among patients despite studies suggesting they're unfounded. Some experts told Yahoo Finance they thought the shot could be a target for more scrutiny under Kennedy's new ACIP. Currently, the shot is covered by insurance because it's recommended for pre-teens through young adults. The CDC lists its full price at over $300 a dose. Even modest costs can dissuade patients from getting vaccinated, according to Loren Adler, associate director at the Brookings Institution's Center on Health Policy. 'We know that folks having to pay $10 for a vaccine limits the uptake somewhat,' he said. As a result, just a small increase in what patients have to pay out of pocket could have ripple effects on public health. One issue to keep an eye on, according to Moselle, is whether state governments step in to require more extensive insurance coverage of vaccines if the federal government walks back some of its recommendations. If they do, vaccine access could start to vary more by where patients happen to live. Jordan Weissmann is a senior reporter at Yahoo Finance. Click here for in-depth analysis of the latest health industry news and events impacting stock prices
New York Post
an hour ago
- New York Post
‘Japanese walking' trend may be better than 10,000 steps a day — and you only need 30 minutes
Americans love to say they're too busy to break a sweat — but a viral fitness trend is blowing that excuse out of the water. Enter 'Japanese walking,' a simple, science-backed exercise routine that promises serious gains in just 30 minutes. 'All movement is medicine, but if you're short on time or want to get the most bang for your buck, this is for you,' strength training coach Eugene Teo said in a recent TikTok. 4 A majority of Americans don't meet the CDC's weekly exercise recommendations. bignai – It's long been said that taking 10,000 steps per day is the key to better health, with research linking regular walking to improved cardiovascular fitness, improved sleep quality and even a lower dementia risk. But that magic number isn't rooted in science. Instead, it originated from a marketing campaign to promote a Japanese pedometer in the 1960s. And let's be real, carving out the two hours it takes to hit that mark isn't going to happen for most Americans. In surveys, nearly half say they're too busy with work and other obligations to exercise at all. Japanese walking might be the solution, offering a more efficient way to achieve the health benefits typically linked to 10,000 steps a day in a fraction of the time. In a 2007 study, Japanese researchers recruited 246 adults with an average age of 63 and divided them into three groups. One group did no walking at all. Another group walked at a steady, moderate pace, aiming for 8,000 or more steps a day at least four times per week. 4 It takes the average person between 1.75 and 2.5 hours to walk 10,000 steps. oasisamuel – The third group practiced interval walking by walking slowly for three minutes, then walking quickly at a hard effort for three minutes. They repeated this cycle for 30 minutes, four or more days per week. Researchers found that interval walking was superior to continuous walking for improving blood pressure, blood glucose levels and body mass index. It also led to the greatest improvements in leg muscle strength and aerobic capacity, which measures the maximum amount of oxygen the body can take in and use during exercise. The low-impact regimen might even hold the key to staying in shape as you get older. A longer-term study found that the Japanese walking method helps protect against the decline in strength and fitness that naturally occurs with aging. 4 Japanese walking can be tailored to fit all fitness levels. lordn – Interval walking is 'one of the most overlooked yet incredibly effective tools for improving long-term health, especially among middle-aged and older adults,' Dr. Ramit Singh Sambyal, a general physician, told Verywell Health. 'By simply alternating between short periods of brisk walking and slower-paced recovery, we engage the cardiovascular system in a much more dynamic way,' he added. Another perk: completing the 30-minute Japanese walking routine four times a week puts you just thirty minutes short of the CDC's recommendation that adults get at least 150 minutes of moderate-intensity aerobic activity per week. Add just one more walking session, or incorporate one of these 30-minute workouts, and you'll be among the few Americans who actually hit that target. 4 Interval walking may be more effective than traditional walking for improving cardiovascular fitness. bongkarn – Tips and tricks to master Japanese walking To make sure you're hitting the right pace, use a fitness tracker that measures your heart rate. During those three minutes of brisk walking, aim for 70% to 85% of your maximum heart rate. When you slow down, let it drop to 40% to 50%. No tracker? No problem. Try the 'talk test.' At a brisk pace, you should be able to say a few words but need to catch your breath quickly. At a leisurely pace, you should be able to chat comfortably. And if you're worried about keeping up a brisk pace for a full three minutes, experts say it's okay to start small. 'Try walking at your regular pace for a few minutes, then pick up the speed for 20 to 30 seconds, and repeat,' Dr. Sarah F. Eby, a sports medicine specialist, told Healthline. 'As your body adapts to this new exercise stimulus, you can gradually increase the duration of the faster walking bouts,' she added.
